GUSA vs SCHD
Goldman Sachs MarketBeta US 1000 Equity ETF vs Schwab US Dividend Equity ETF
Which is better, GUSA or SCHD?
Large Cap Blend against Large Cap Value.
SCHD has a lower expense ratio. GUSA led over 3Y and the full window, SCHD over 1Y. GUSA is less concentrated, with 34.4% of the fund in its ten largest positions against 41.8%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | GUSA | SCHD |
|---|---|---|
| Expense Ratio | 0.10% | 0.06%Best |
| AUM | $2.4B | $112.1B |
| Dividend Yield | 0.99% | 3.00% |
| Holdings | 1,009 | 103 |
| YTD Return | +11.41% | +24.59%Best |
| 1Y Return | +16.82% | +28.14%Best |
| 3Y Return (annualized) | +20.17%Best | +15.58% |
| 5Y Return (annualized) | - | +9.90% |
| Volatility (annualized) | 15.4% | 15.0%Best |
| Max Drawdown | -19.6% | -16.1%Best |
| $10,000 over 4.4 years | $17,888Best | $15,131 |
| Top 10 Weight | 34.4%Best | 41.8% |
| Fund Family | Goldman Sachs Asset Management | Charles Schwab Asset Management |
| Category | Equity | Equity |
| Style | Large Cap Blend | Large Cap Value |
| Inception | Apr 5, 2022 | Oct 20, 2011 |
Volatility and max drawdown, and the $10,000 over 4.4 years row, are measured over the window both funds cover: Apr 12, 2022 to Sep 10, 2026 (4.4 years).
GUSA vs SCHD growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 4.4 years both funds cover.
GUSA vs SCHD Performance
Goldman Sachs MarketBeta US 1000 Equity ETF (GUSA) is an ETF from Goldman Sachs Asset Management and Schwab US Dividend Equity ETF (SCHD) is an ETF from Charles Schwab Asset Management. Over the past year GUSA returned +16.82% while SCHD returned +28.14%. Year to date, GUSA is up 11.41% versus a gain of 24.59% for SCHD.
Over three years, GUSA compounded at +20.17% per year against +15.58% for SCHD. Across the full 4-year window we track, GUSA has the edge at +14.13% annualized vs +9.87%.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
GUSA has been the more volatile fund, with annualized monthly volatility of 15.4% compared with 15.0% for SCHD. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -19.6% for GUSA and -16.1% for SCHD. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.69. They move together some of the time, and apart the rest.
Fees and Cost Over Time
GUSA charges 0.10% per year while SCHD charges 0.06%. On a $10,000 position that is $10 vs $6 annually, a gap of $4 per year that compounds over a long holding period. On income, GUSA currently yields 0.99% against 3.00% for SCHD.
Holdings Overlap
7.4% of GUSA's money is in holdings SCHD also owns. 96.5% of SCHD's money is in holdings GUSA also owns.
Most of SCHD is already inside GUSA. Owning both mostly buys the same companies twice.
55 positions in common, counted across the 881 positions we hold weights for in GUSA and 100 in SCHD, against full books of 1,009 and 103.
What only one of them owns
Our book lists 44 positions for SCHD that do not appear in our book for GUSA (3.4% of the fund), and 762 for GUSA that do not appear in SCHD (90.0%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
Top Shared Holdings
| Stock | Weight in GUSA | Weight in SCHD | Difference |
|---|---|---|---|
| MRKMerck & Co. Inc. | 0.47% | 4.77% | 4.30% |
| AMGNAmgen Inc. | 0.31% | 4.70% | 4.39% |
| ABTAbbott Laboratories | 0.27% | 4.69% | 4.42% |
| KOCoca Cola Co. | 0.47% | 4.17% | 3.70% |
| CVXChevron Corp. | 0.53% | 4.02% | 3.49% |
| HDHome Depot Inc/The | 0.47% | 3.88% | 3.41% |
| UNHUnitedhealth Group Inc. | 0.50% | 3.82% | 3.32% |
| PGProcter & Gamble Company | 0.46% | 3.83% | 3.37% |
| VZVerizon Communications, Inc. | 0.28% | 3.97% | 3.69% |
| COPConocophillips Co | 0.22% | 3.94% | 3.72% |
96.5% of SCHD is already inside GUSA.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, GUSA or SCHD?
GUSA has an expense ratio of 0.10% while SCHD charges 0.06%. SCHD is the cheaper option, by $4 a year on a $10,000 investment.
Which performed better, GUSA or SCHD?
Over the past year GUSA returned +16.82% vs +28.14% for SCHD, so SCHD leads on 1-year performance. Over the longest common window we track (4 years), GUSA annualized +14.13% vs +9.87% for SCHD. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, GUSA or SCHD?
GUSA has been the more volatile fund at 15.4% annualized versus 15.0% for SCHD. Worst drawdown: GUSA -19.6% vs SCHD -16.1%.
Should I hold both GUSA and SCHD?
GUSA and SCHD have a monthly-return correlation of 0.69, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between GUSA and SCHD?
96.5% of SCHD's money is in holdings GUSA also owns. 96.5% of SCHD's is in holdings GUSA also owns. They hold 55 positions in common, counted across the 881 positions we hold weights for in GUSA and 100 in SCHD.
Which pays a higher dividend, GUSA or SCHD?
GUSA yields 0.99% while SCHD yields 3.00%, so SCHD currently pays the higher dividend yield.
Is SCHD better than GUSA?
SCHD has a lower expense ratio. GUSA led over 3Y and the full window, SCHD over 1Y. GUSA is less concentrated, with 34.4% of the fund in its ten largest positions against 41.8%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.